Apixaban
Overview
Apixaban is an oral anticoagulant medication that works by inhibiting factor Xa, an important component in the blood coagulation pathway. It is commonly used to prevent and treat blood clots and reduce the risk of stroke in patients with atrial fibrillation.
API suppliers (52)
Suppliers of Apixaban evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 44 of 52 suppliers.
25 of 52 hold a GMP certificate on record in the EU or UK registers
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)India1 active DMF
- HIKAL LTDPakistan1 active DMF
- Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
- Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- DELMAR CHEMICALS INCCanada1 active DMF
- SCINOPHARM TAIWAN LTDTaiwan1 active DMF
- HONOUR LAB LTDIndia1 active DMF GMP on record
- GOLD PHARMA PRIVATE LIMITEDIndia1 active DMF
- Maithri Laboratories Private LimitedIndia1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- RAKSHIT DRUGS PRIVATE LTD1 active DMF
- INDOCO REMEDIES LTDIndia1 active DMF GMP on record
- Micro Labs Usa1 active DMF
- Zydus Lifesciences LimitedIndia1 active DMF GMP on record
- MEDICHEM MANUFACTURING (MALTA) LTDMalta1 active DMF GMP on record
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- Natco PharmaIndia1 active DMF GMP on record
- Unichem Laboratories Ltd.India1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
- JUBILANT BIOSYS LTDIndia1 active DMF
- Neuland Laboratories LimitedIndia1 active DMF
- Jiangxi Synergy Pharmaceutical Co., LtdChina1 active DMF
Showing 25 of 52 suppliers — see the full list in the app.
Patent & exclusivity (US)
Per the FDA Orange Book (8 approved US products), the latest listed US patent on Apixaban expires 22 May 2041 and exclusivity 17 Oct 2028. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Apixaban? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.